Paying for cures:
Ensuring patient access and system sustainability

February 12, 2019 • Washington, DC

Image Image Image Image

Learn Precision Financing solutions with innovation leaders and national policymakers at this one-day conference

Hosted by MIT Center for Biomedical Innovation NEWDIGS Initiative


Image Image

Image

Paying for cures: Ensuring patient access and system sustainability

February 12, 2019 • Washington, DC

Image Image Image Image

Registration is free but seating is limited. Please register early to reserve your seat.

Register now

Learn Precision Financing solutions with innovation leaders and national policymakers at this one-day conference

Hosted by MIT Center for Biomedical Innovation NEWDIGS Initiative

Image

Featured Keynotes

  • Senator Bill Cassidy

    Senator Bill Cassidy

  • Senator Sheldon Whitehouse

    Senator Sheldon Whitehouse

This widely attended event will include:

  • Policymakers / legislators on the Hill to identify the challenges patients are going to face and make sure they have access to transformational therapies
  • Industry senior leaders and heads of government affairs to help articulate challenges and shape direction for future of innovation.
  • Regulators to evolve the system based on new strategies and emerging tools
  • Payers to learn new financing models
  • Patients and providers to advocate for progress and access

Understand the future of curative therapies and their financing challenges

Learn new Precision Financing strategies and tools

Connect with system stakeholders to solve problems

In this one day conference, grasp the challenges and solutions to making cures accessible to patients and sustainable by the healthcare system.


Sponsors

Image Image Image Image Image Image

A collaboration for practical solutions
The Paying for Cures conference will share research and recommendations compiled over nearly three years in the NEWDIGS Consortium at MIT. The collaboration included perspectives across the healthcare innovation spectrum to develop patient-centered, system-sustainable solutions.

See the research

Speakers
  • Joe Alvarnas

    Joe Alvarnas, MD
    Vice President, Government Affairs & Senior Medical Director, Employer Strategy, City of Hope

  • Usman “Oz” Azam, MD
    President & CEO, Tmunity Therapeutics

  • Marc Boutin

    Marc Boutin, JD
    CEO, National Health Council

  • Tim Brent

    Tim Brent
    Senior Director, Business Development, National Hemophilia Foundation

  • Chuck Buckler

    Chuck Bucklar
    Group Vice President, Commercial Operations, North America, BioMarin Pharmaceutical Inc.

  • Kim Caldwell

    Kim Caldwell, RPh
    Principal, Texas Star Healthcare Consulting, LLC (formerly Division Director, Medicare Drug Benefit Group, CMS; & Vice President of Pharmacy Professional Affairs, Humana)

  • Brian Carey

    Brian Carey
    Partner, Co-Chair, Foley-Hoag LLP

  • Senator Bill CassidySenator Bill Cassidy
    (R) U.S. Senator for Louisiana

  • Lovena Chaput
    Vice President, Managed Markets & Reimbursement, AveXis

  • Mike Ciarametaro, MBA
    Vice President Research, National Pharmaceutical Council

  • Rena Conti

    Rena Conti, PhD
    Associate Research Director, Biopharma and Public Policy, Institute for Health System Innovation and Policy, Boston University Questrom School of Business

  • Gregory Daniel

    Gregory Daniel, PhD, MPH
    Deputy Director, Policy, Duke – Robert J. Margolis MD, Center for Health Policy & Clinical Professor, Fuqua School of Business

  • Bob Galvin

    Bob Galvin, MD
    Chief Executive Officer, Equity Healthcare (former Executive Director, Health Services & Chief Medical Officer, General Electric)

  • Anish Goel, PhD
    Beta-thalassemia major patient

  • David Goldston

    David Goldston, PhD
    Director, MIT Washington D.C. Office

  • Darin Gordon

    Darin Gordon
    Founding Partner, Speire Healthcare Strategies, LLC (former Director, Tennessee Medicaid program—TennCare)

  • Jonathan Gruber, PhD
    Ford Professor of Economics, MIT and Director, Health Care Program, National Bureau of Economic Research

  • Gigi Hirsch, MD
    Executive Director, Center for Biomedical Innovation and Program Director, NEWDIGS

  • Mehb Khoja

    Mehb Khoja, FSA, MAAA
    President, Medical Risk Managers Inc. (MRM)

  • Krishna Komanduri

    Krishna Komanduri, MD
    Kalish Family Chair in Stem Cell Transplantation; Professor of Medicine and Associate Director, Clinical Innovation, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine

  • Janet Lambert

    Janet Lambert, MBA
    CEO, Alliance for Regenerative Medicine (ARM)

  • Jeff Myers

    Jeff Myers
    EVP Strategy and External Relations,  CareSource (former president and CEO of Medicaid Health Plans of America (MHPA))

  • Ed Pezalla

    Edmund Pezalla, MD, MPH
    CEO Enlightenment Bio-consulting (former Vice President, National Medical Director, Pharmaceutical Policy and Strategy, Aetna)

  • Murray Ross

    Murray Ross, PhD
    Vice President, Kaiser Permanente

  • Peter Saltonstall

    Peter Saltonstall
    President and CEO, National Organization for Rare Diseases (NORD)

  • Michael Sherman

    Michael Sherman, MD, MBA, MS
    Chief Medical Officer and Senior Vice President, Harvard Pilgrim Health Care

  • Mark Trusheim

    Mark Trusheim, MSc
    Strategic Director, NEWDIGS Initiative, MIT Center for Biomedical Innovation

  • Steve Usdin

    Steve Usdin
    Senior Editor (Washington), Head Policy & Regulation, BioCentury and BioCentury Innovations

  • Krystyn Van Vliet

    Krystyn Van Vliet, PhD
    Associate Provost and Professor of Materials Science & Engineering & Biological Engineering, MIT

  • Senator Sheldon Whitehouse

    Senator Sheldon Whitehouse
    (D) U.S. Senator for Rhode Island

  • Colin Young

    Colin M. Young, PhD
    Director Drug Development Pipeline Research, MIT FoCUS Project

Speakers

Joe Alvarnas
M.D. VP Government Affairs, City of Hope

Usman “Oz” Azam
President & CEO, TMUNITY

Marc Boutin
CEO, National Health Council

Tim Brent
Sr. Director of Business Development, National Hemophilia Foundation

Chuck Bucklar
Group Vice President, Commercial Operations, North America, BioMarin Pharmaceutical Inc.

Kim Caldwell
Principal, Texas Star Healthcare Consulting, LLC (formerly Division Director, Medicare Drug Benefit Group, CMS; & Vice President of Pharmacy Professional Affairs, Humana)

Brian Carey
Partner and Co-Chair Administrative Law Department, Foley-Hoag LLP

Lovena Chaput
Vice President, Managed Markets & Reimbursement, AveXis

Senator Bill Cassidy
United States Senate

Mike Ciarametaro
VP Research, National Pharmaceutical Council

Rena Conti
Associate Professor, Markets, Public Policy, and Law; Associate Research Director, Biopharma and Public Policy, Institute for Health System Innovation and Policy, Boston University Questrom School of Business

Gregory Daniel
Deputy Director & Clinical Professor, Fuqua School of Business, Duke Margolis Center for Health Policy, Washington D.C. Office

Bob Galvin
Chief Executive Officer, Equity Healthcare, Blackstone

David Goldston
Director, MIT Washington D.C. Office

Darin Gordon
President & CEO, Gordon & Associates (former Director, Tennessee Medicaid program-TennCare)

Jonathan Gruber
Ford Professor of Economics, MIT and Director, Health Care Program, National Bureau of Economic Research

Gigi Hirsch
Executive Director, MIT Center for Biomedical Innovation NEWDIGS Initiative

Mehb Khoja
President, Medical Risk Managers Inc.

Krishna Komanduri
Kalish Family Chair, Professor of Medicine, Director, Sylvester Cancer Center Adult Stem Cell Transplant Program

Janet Lambert
CEO, Alliance for Regenerative Medicine (ARM)

Edmund Pezalla
CEO Enlightenment Bio-consulting (former Vice President, National Medical Director, Pharmaceutical Policy and Strategy, Aetna)

Peter Saltonstall
President and CEO, National Organization for Rare Diseases (NORD)

Michael Sherman
Chief Medical Officer, Harvard Pilgrim Health Care

Mark Trusheim
Strategic Director, NEWDIGS Initiative, MIT Center for Biomedical Innovation

Steve Usdin
Senior Editor at BioCentury

Krystyn Van Vliet
Associate Provost and Professor of DMSE and BE, MIT

Senator Sheldon Whitehouse
United States Senate

Colin M. Young
Director Drug Development Pipeline Research, MIT FoCUS Project

Agenda

Part 1: Understanding curative and durable therapies
Why are we here? The science, patients and system readiness for curative therapies

Cell & Gene Therapies Drug Development Pipeline

Part 2: Challenges to accessibility
Financial Challenges Imposed by Curative Therapies: Real or Imagined?

Keynote: Senator Cassidy

The FoCUS Project: Precision Financing Solutions

Part 3: Clearing the way for cures
Putting Theory into Practice

Identifying Opportunities for Enabling Precision Financing

Keynote: Senator Whitehouse


Registration
Register now

Registration is free but seating is limited. Please register early to reserve your seat.

LOCATION

National Press Club
529 14th St NW, Washington, DC 20045
February 12, 2019